Nephropathy in Type 2 Diabetes Mellitus

Diabetic nephropathy is kidney damage that develops when persistently high blood sugar injures the tiny filtering vessels inside the kidneys. It is a serious complication of type 2 diabetes mellitus and one of the most common causes of end-stage kidney disease in South and Southeast Asia, where type 2 diabetes rates have risen sharply over the past two decades.

Medicine used to treat Nephropathy in Type 2 Diabetes Mellitus

Avapro

Irbesartan

150 · 300mg

Indicated to mitigate high blood pressure, formulated to support renal protection in diabetic patients and target angiotensin receptor pathways.

From $1.06 / tablet View

How nephropathy in type 2 diabetes is managed

The central aim is slowing the decline in kidney function. Tight glucose control and blood pressure management are the cornerstones. Medicines that block the renin-angiotensin system, including irbesartan and related agents, reduce protein leakage into the urine (proteinuria) and slow structural damage to the kidneys. These agents are also used to manage the raised blood pressure that frequently accompanies kidney disease; you can find related treatments in the heart and blood pressure category. Dietary changes, particularly limiting sodium and protein intake, support these effects. Regular monitoring of kidney function tests (eGFR, creatinine) and urine protein helps guide treatment adjustments over time.

Any sudden drop in urine output, significant swelling of the legs, or marked shortness of breath should be assessed promptly.